When was ImprimisRx founded?

ImprimisRx was founded in 1998 and raised its 1st funding round 9 years after it was founded.

Where is ImprimisRx located?

ImprimisRx is headquartered in Roxbury Township, United States.

How many employees does ImprimisRx have?

As of Sep 30, 2026, the latest employee count at ImprimisRx is 134.

Is ImprimisRx a funded company?

ImprimisRx is a funded company, having raised a total of $80K across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2007.

When was the latest funding round of ImprimisRx?

ImprimisRx's latest funding was a $***** Post IPO round on Apr 05, 2019, with participation from 0 investor. Its primary sector is Traditional Pharmaceuticals. Globally, the Traditional Pharmaceuticals sector has seen $1.29B in funding in 2026 to date.

Where does ImprimisRx rank among its competitors?

ImprimisRx ranks 4th amongst 89 active competitors, of which 5 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Exela Pharma, which secured $28.3M in Sep, 2025.

Who are the top competitors of ImprimisRx?

ImprimisRx's top competitors include Gufic Group, Sagent Pharma and JAMP Pharma. Among them, Exela Pharma secured the most recent funding round in September, 2025.

ImprimisRx - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: www.imprimisrx.com/s/
Social
Email ID: *****@theirapp.com
Phone Number: +1 **********

Key Metrics

Founded Year

1998

Location

Roxbury Township, United States

Stage

Seed

Total Funding

$80K in 8 rounds

Latest Funding Round

Post IPO, Apr 05, 2019, $*****

Ranked

4^th among 89 active competitors

Employee Count

134 as on Sep 30, 2026

Investment & Acquisitions

Sinus Dynamics & 3 more

Similar Companies

Gufic Group & 98 more

View ImprimisRx's full profile

ImprimisRx is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Ingenious Med Inc CIN: 1368644 , United States, Active		$5M - $25M (As on Jan 03, 2013)	-	-
Imprimis Pharmaceuticals, Inc. CIN: 450567010 , United States, Active	Dec 31, 1999	$10M - $50M (As on Dec 31, 2017)	302 (As on Dec 31, 2024)	-

ImprimisRx has raised a total funding of $80K over 8 rounds. Its first funding round was on 2007.

Here is the list of recent funding rounds of ImprimisRx:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 05, 2019	1883292	Post IPO	5531712	1259385	1095899	8046780
Dec 30, 2016	2712500	Post IPO	9731110	9573665	5529506	8952376
Jan 01, 2015	6674938	Post IPO	2593899	7423559	8748650	2265211

Access funding benchmarks and valuations. Sign up today!

View details of ImprimisRx's funding rounds and investors

The founders of ImprimisRx is Mark L Baum.

Here are the details of ImprimisRx's key team members:

Mark L Baum: Founder & CEO of ImprimisRx and founder of 1 other company.
Contact Info: 1 email address

View details of ImprimisRx's Founder profiles and Board Members

ImprimisRx's employee count trend

ImprimisRx has 134 employees as of Sep 26. Here is ImprimisRx's employee count trend over the years:

Uncover ImprimisRx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ImprimisRx include Gufic Group, Sagent Pharma and JAMP Pharma. Here is the list of Top 10 competitors of ImprimisRx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Gufic Group 1970, Mumbai (India), Public	Manufacturer of lyophilized injections and pharmaceutical products	-	-	52/100
2nd	Sagent Pharma 2006, Schaumburg (United States), Acquired	Provider of injectable generic pharmaceuticals	$153M	Zhejiang Hisun Pharmaceuticals, MidCap Financial ... & 3 others	51/100
3rd	JAMP Pharma 1988, Boucherville (Canada), Late Stage	Manufacturer of injectables	-	Fonds de solidarite FTQ	51/100
4th	ImprimisRx 1998, Roxbury Township (United States), Seed	Developer of proprietary sterile and topical drug formulations	$80K	-	50/100
5th	Kelun Pharmaceutical 1996, Chengdu (China), Public	Manufacturer of pharmaceutical products and related services	-	Yonghua Capital	49/100
6th	Innopharma 2005, Piscataway (United States), Acquired	Manufacturer of injectable pharmaceutical products	$23M	Thomas, McNerney & Partners, Comerica & 1 others	49/100
7th	Nanolek 2011, Moscow (Russia), Late Stage	Manufacturer of biopharmaceuticals and vaccines	$43.7M	Sberbank, Rusnano	48/100
8th	Otsuka Pharmaceutical India 2012, Ahmedabad (India), Unfunded	Manufacturer of intravenous infusions and clinical nutrition products	-	-	48/100
9th	Exela Pharma 2005, Lenoir (United States), Series B	Manufacturer of sterile injectable pharmaceutical products and CDMO services	$6.67M	Trinity Capital, Baruch Future Ventures & 3 others	46/100
10th	Amphastar Pharmaceuticals 1996, Rancho Cucamonga (United States), Public	Manufacturer of injectable and inhalation products	-	YFY, Yet2ventures & 2 others	46/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on ImprimisRx's competitors? Click here to see the top ones

ImprimisRx has not made any investments yet. ImprimisRx has made 4 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Oct 20, 2015	Acquisition	Sinus Dynamics	2003	Westlake Village (United States)
Oct 2015	Acquisition	Tagaseptic		-
Oct 2015	Acquisition	Asl Pharmacy	2005	Westlake Village (United States)